Corporate results:

  • Ryanair - Annual net profit slightly exceeds expectations.

In other news:

  • The American justice blocks the merger between American Airlines and JetBlue.
  • Instagram (Meta Platforms) prepares a rival to Twitter for the summer.
  • Micron Technology - China's cyberspace regulator announced Sunday that the U.S. semiconductor maker's products did not meet network security criteria and would be banned from key infrastructure operators.
  • GAM Holding rejects Taure's offer and still recommends Liontrust's.
  • Blackstone announced that it has acquired a 100% stake in jewelry certification group International Gemological Institute (IGI) from China's Fosun and the company's founding family.
  • Aliaxis proposes to buy Uponor at EUR 25.75 per share.
  • Legal battle between the president of Ferrari (John Elkann) and his mother (Margherita Agnelli) over the Agnelli legacy.
  • Sacyr is reportedly in talks to sell 45% of the Irish N6 freeway to Bestinver.
  • Siemens Energy is selling its stake in Windar Renovables to Bridgepoint.
  • China reports that Micron products failed its cybersecurity test.
  • NatWest will buy back £1.26bn of its own shares.
  • Nvidia announced that it has collaborated with the University of Bristol in the development of a new supercomputer using its own chips to compete with Intel and Advanced Micro Devices.
  • Albemarle gained 1.4% in pre-market trading after it signed an agreement with Ford Motor to supply 100,000 metric tons of lithium hydroxide for use in batteries, which should enable the carmaker to increase its production of electric vehicles.
  • Exxon Mobil succumbs to lithium fever, according to the WSJ.
  • Equinor, Shell, Exxon Mobil close in on LNG terminal deal in Tanzania.
  • Applied Materials - The U.S. semiconductor equipment maker said Monday it plans to invest up to $4 billion in a research center in the heart of Silicon Valley to improve chip production.
  • Genmab and AbbVie announce U.S. FDA approval of Epkinly for treatment of diffuse large B-cell lymphoma.
  • BioArctic and Eisai seek approval for an Alzheimer's drug in Britain.
  • Nike may have mis-listed independent contractors, exposing it to tax fines exceeding $500 million, according to the Guardian.
  • Today's main earnings reports: Heico, Ryanair, Zoom Video Communications...The full earnings calendar is here.